Loading company…
Shotsy provides a tracking app for people using GLP-1 medications.
Shotsy’s app helps users of GLP-1 medications log injections, side effects and health measures such as weight, protein, water and calorie intake. It is designed for people managing treatment for type 2 diabetes or obesity. The company is based in the US. In February 2025, it raised USD 2.25 mn in Seed funding led by Coalition Operators and Springbank Collective.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in